CRELUX

CRELUX, part of WuXi AppTec HitS unit, is a global provider of structure based drug discovery solutions. We have been delivering customized and integrated services in drug discovery, X-ray crystallography, protein supply, biophysical analysis and fragment screening, to support small and large molecule, as well as biopharmaceutical drug discovery, for more than a decade. Our mission is to enable our clients to perform their work faster, more efficiently and more successfully. Integrating the comprehensive portfolio of services offered by our parent company WuXi AppTec, CRELUX offers a unique opportunity for our collaborators to accelerate discovery activities... We started as a team of experts in protein production, crystallography and biophysics in 2005 with a mission to expedite structure-based drug discovery and with a vision "your discovery, our solutions"... In 2016 we were acquired by WuXi AppTec, a company that provides a broad portfolio of R&D and manufacturing services that..

Also known as: CRELUX GmbH

Registration numbers: HRB 156662 (W)

VAT numbers: DE 242220245

Primary location: Martinsried Germany